NCT00808145View on ClinicalTrials.gov

Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2009

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Gemcitabine / Cisplatin / Sorafenib

All patients will receive gemcitabine 1000mg/m2 cisplatin 30mg/m2 sorafenib 400mg orally twice daily

Trial Locations (1)

01805

Lahey Clinic, Burlington

Sponsors

Lead Sponsor

Lahey Clinic
All Listed Sponsors
lead

Lahey Clinic

OTHER